| Autor: |
de Stoppelaar FM; Department of Clinical Pharmacy and Toxicology, University Hospital Maastricht, The Netherlands., Stolk LM, Beysens AJ, Stappers JL, Gorgels AP |
| Jazyk: |
angličtina |
| Zdroj: |
Pharmacy world & science : PWS [Pharm World Sci] 1999 Oct; Vol. 21 (5), pp. 233-8. |
| DOI: |
10.1023/a:1008792421982 |
| Abstrakt: |
The pharmacokinetics, efficacy and safety of metoprolol tartrate 25 mg fatty suppositories were studied in 5 healthy volunteers and in 8 patients suffering from instable angina pectoris. Metoprolol 25 mg capsules were used as a control oral dosage form. Metoprolol showed a considerable rectal bioavailability (AUC, C max) and was absorbed quickly from the rectum (T max). In both groups rectal bioavailability was comparable. However, oral bioavailability was much lower in the volunteer group than in the patient group. Furthermore, ratios of metoprolol/alpha-OH-metoprolol concentrations in plasma and urine gave an indication for a partial avoidance of the first pass effect after rectal administration. Further research is necessary to define an exact rectal dosage of metoprolol. In all patients, a substantial drop in heart rate, systolic and diastolic blood pressure was seen after administration of the first suppository. Metoprolol suppositories appear to be an effective, safe and suitable alternative for patients who are in need for beta blocking medication and who are unable to take oral medication for a certain amount of time. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink